MedTrace Logo

Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin

NCT01039662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2011-06-23

No results posted yet for this study

Summary

This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on dietary glycemic index.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

L-arabinose and indigestible dextrin

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Unitika Ltd.

    collaborator INDUSTRY

  • Hiroshima University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01039662 on ClinicalTrials.gov